Raffles Medical Group Ltd
RAFLF
$0.8073
$0.05737.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.10% | 4.17% | 5.57% | 6.73% | -49.34% |
| Total Depreciation and Amortization | 8.66% | 3.74% | 31.52% | 32.97% | 3.48% |
| Total Amortization of Deferred Charges | -- | -- | -47.97% | -47.39% | -- |
| Total Other Non-Cash Items | 92.50% | 92.84% | 113.17% | 113.32% | 88.60% |
| Change in Net Operating Assets | 116.85% | 116.09% | -117.23% | -117.41% | -128.08% |
| Cash from Operations | 70.50% | 62.78% | -16.45% | -15.53% | -73.00% |
| Capital Expenditure | 74.64% | 75.78% | 30.47% | 29.71% | -21.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -99.58% | -99.58% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.14% | -32.34% | 20.68% | 22.01% | -0.60% |
| Cash from Investing | 97.97% | 98.06% | 52.12% | 51.59% | -18.82% |
| Total Debt Issued | -97.62% | -97.62% | -76.53% | -76.53% | 1.56% |
| Total Debt Repaid | 83.25% | 83.25% | 48.95% | 48.95% | -2.60% |
| Issuance of Common Stock | 65.74% | 65.74% | -97.58% | -97.58% | -95.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.09% | -3.20% | -- | -- | 37.59% |
| Other Financing Activities | 48.56% | 48.56% | 8.16% | 8.16% | -69.45% |
| Cash from Financing | -21.88% | -16.37% | -67.56% | -69.40% | 25.14% |
| Foreign Exchange rate Adjustments | -313.17% | -303.50% | 707.06% | 716.47% | 183.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.41% | 64.11% | -35.38% | -34.67% | -154.68% |